Last updated on April 17, 2014 at 17:30 EDT

Elsevier Honors the 2013 Nobel Laureates

October 17, 2013

AMSTERDAM, October 17, 2013 /PRNewswire/ –

Nobel tribute website provides free access to research published by 2013

Nobel Laureates

Elsevier [http://www.elsevier.com/_nocache ], a world-leading provider of scientific,
technical and medical information products and services, today announced that in honor of
the 2013 Nobel Laureates it has launched its Nobel Prize tribute website
[http://www.elsevier.com/about/history/nobel-tribute/_nocache ] (
http://www.elsevier.com/nobel). The site provides an overview of the Laureates’
ground-breaking research as well as their connections with Elsevier. In addition, free
access is provided to some of their most influential research papers published in Elsevier

Ron Mobed, CEO of Elsevier, said, “We are honored to have had the opportunity to work
with these remarkable scholars. Over the years we have been privileged to see their
connections to Elsevier either through publishing their ground-breaking work in our
journals and books, or through their efforts as editors, editorial board members and
reviewers. We wholeheartedly congratulate all winning 2013 Nobel Laureates and thank them
for their contributions, not only to Elsevier, but to society as a whole.”

Elsevier is proud to recognize the Nobel laureates’ revolutionary research:

Medicine: Dr. James E. Rothman, Dr. Randy W. Schekman and Dr. Thomas C. Suedhof were
jointly awarded the 2013 Nobel Prize in Medicine or Physiology
[http://www.nobelprize.org/nobel_prizes/medicine/laureates/2013/press.html ] “for their
discoveries of machinery regulating vesicle traffic, a major transport system in our
cells”. They revealed the critical process of the movement of molecules through cells,
paving the way for targeted medication for a variety of neurological and immunological
diseases, such as diabetes, autism and Parkinson’s disease.

James Rothman was the Editor for Methods in Enzymology
[http://store.elsevier.com/categoryController.jsp?categoryId=EST_SER-47&utm_source=publicity&utm_medium=pressrls&utm_campaign=nobel ]
(1992 edition) and is an Editorial Board Member
for FEBS Letters [http://www.journals.elsevier.com/febs-letters ]. Dr. Schekman published
in among others Cell [http://www.cell.com ], Developmental Cell
[http://www.cell.com/developmental-cell ], Cell Biology
[http://www.cell.com/trends/cell-biology ] and Cell Host & Microbe
[http://www.cell.com/cell-host-microbe ]. He has also been awarded the 2013 Otto Warburg
[http://www.journals.elsevier.com/bba-biomembranes/news/gbm-awards-2013-otto-warburg-medal-prof-randy-schekman ]
by the German Society for Biochemistry and Molecular Biology (GBM).
Dr. Suedhof published in Cell [http://www.cell.com ] and Neuron
[http://www.cell.com/neuron ], and was a contributing author to Handbook of Cell Signaling
[http://store.elsevier.com/product.jsp?isbn=9780080533575&utm_source=publicity&utm_medium=pressrls&utm_campaign=nobel ]
,Parkinson’s Disease
[http://store.elsevier.com/product.jsp?isbn=9780123740281&utm_source=publicity&utm_medium=pressrls&utm_campaign=nobel ]
and others.

Physics: Dr. Francois Englert and Dr. Peter W. Higgs were jointly awarded the 2013
Nobel Prize in Physics
[http://www.nobelprize.org/nobel_prizes/physics/laureates/2013/press.html ] for their
“theoretical discovery of a mechanism that contributes to our understanding of the origin
of mass of subatomic particles, and which recently was confirmed through the discovery of
the predicted fundamental particle, by the ATLAS and CMS team experiments at CERN’s Large
Hadron Collider”. In 1964, Dr. Englert and Dr. Higgs, independently of each other,
proposed a similar theory of how matter acquires mass. A half century later, in July 2012,
their proposed theory was confirmed at CERN [http://home.web.cern.ch ] in Switzerland with
the discovery of the Higgs Boson.

Dr. Englert and Dr. Higgs frequently published in Physics LettersB
[http://www.journals.elsevier.com/physics-letters-b ] and Nuclear PhysicsB
[http://www.journals.elsevier.com/nuclear-physics-b ]. Dr.Englert was also a contributing
author to Recent Developments in Quantum Field Theory
[http://store.elsevier.com/product.jsp?isbn=9780444598394&utm_source=publicity&utm_medium=pressrls&utm_campaign=nobel ]
. The two ground-breaking CERN studies in 2012 confirming the
Higgs Boson were published in Physics LettersB
[http://www.journals.elsevier.com/physics-letters-b ].

Chemistry: Dr. Martin Karplus, Dr. Michael Levitt and Dr. Arieh Warshel were jointly
awarded the 2013 Nobel Prize in Chemistry
[http://www.nobelprize.org/nobel_prizes/chemistry/laureates/2013/press.html ] “for the
development of multiscale models for complex chemical systems.” They developed new
computer models combining quantum and Newtonian physics for the first time. Their method
of modeling has widespread applications in that it can be used to model virtually every
chemical reaction.

Dr. Karplus is Editorial Board member of Structure [http://www.cell.com/structure ]
and has published in among others Chemical Physics Letters
[http://www.journals.elsevier.com/chemical-physics-letters ], Biophysical Chemistry
[http://www.journals.elsevier.com/biophysical-chemistry ] and Biophysical Journal
[http://www.cell.com/biophysj ]. Dr. Levitt is an Editorial Board Member of Current
Opinion in Structural Biology
[http://www.journals.elsevier.com/current-opinion-in-structural-biology ] and has published
in Current Opinion in Structural Biology
[http://www.journals.elsevier.com/current-opinion-in-structural-biology ], Structure
[http://www.cell.com/structure ], and Biophysical Journal [http://www.cell.com/biophysj ].
Dr. Warshel has published in among others, Biophysical Journal
[http://www.cell.com/biophysj ], BBA – Bioenergetics
[http://www.journals.elsevier.com/bba-bioenergetics ], Chemical Physics Letters
[http://www.journals.elsevier.com/chemical-physics-letters ] and FEBS Letters
[http://www.journals.elsevier.com/febs-letters ].

Economics: Dr. Eugene F. Fama, Dr. Lars Peter Hansen and Dr. Robert J. Shiller were
jointly awarded the 2013 Sveriges Riksbank Prize in Economic Sciences
[http://www.nobelprize.org/nobel_prizes/economic-sciences/laureates/2013/press.html ] for
“their empirical analysis of asset prices.” They developed a method of analyzing stock and
bond prices over the course of longer periods. With their research, they have created a
method to make accurate assumptions about asset prices, allowing investors and individuals
to make informed decision on how to use their savings.

Dr. Fama is an Advisory Editor for the Journal of Financial Economics
[http://www.journals.elsevier.com/journal-of-financial-economics/editorial-board ] and has
published in Journal of Financial Economics
[http://www.journals.elsevier.com/journal-of-financial-economics ] and the Journal of
Monetary Economics [http://www.journals.elsevier.com/journal-of-monetary-economics ]. Dr.
Hansen is a Co-Editor for Handbook of Financial Econometrics: Tools and Techniques
[http://store.elsevier.com/Handbook-of-Financial-Econometrics-Vol-1/isbn-9780444508973 ]
and has published in Journal of Economic Theory
[http://www.journals.elsevier.com/journal-of-economic-theory ], Journal of Economic
Dynamics and Control
[http://www.journals.elsevier.com/journal-of-economic-dynamics-and-control ], Journal of
Econometrics [http://www.journals.elsevier.com/journal-of-econometrics ] and others. Dr.
Shiller’s work can be found in Journal of the Japanese and International Economies
[http://www.journals.elsevier.com/journal-of-the-japanese-and-international-economies ],
Economics Letters [http://www.journals.elsevier.com/economics-letters ], Journal of
Econometrics [http://www.journals.elsevier.com/journal-of-econometrics ], Journal of
Monetary Economics [http://www.journals.elsevier.com/journal-of-monetary-economics ] and
Journal of Economic Behavior & Organization
[http://www.journals.elsevier.com/journal-of-economic-behavior-and-organization ].

For more information about the 2013 Nobel Laureates, their awarded research and
connections with Elsevier go to: http://www.elsevier.com/nobel
[http://www.elsevier.com/about/history/nobel-tribute/_recache ]

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], SciVal [http://info.scival.com ], Reaxys
[http://www.elsevier.com/reaxys ], ClinicalKey [https://www.clinicalkey.com ] and Mosby’s
Suite [http://www.confidenceconnected.com ], which enhance the productivity of science and
health professionals, helping research and health care institutions deliver better
outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com/Pages/Home.aspx ], a world leading provider of professional
information solutions. The group employs more than 30,000 people, including more than
15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies,
Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam
and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam:
REN; New York: RUK and ENL.

        Media contact
        Sacha Boucherie
        Press Officer, Elsevier

SOURCE Elsevier

Source: PR Newswire